John Bissell : Yes. So with a plant like Origin 1. And by the way, hey, how are you? So with a plant like Origin 1, one of the interesting components of it is what’s the right way to instrument a plant like that. And especially with a first-of-a-kind plant, we really want to understand as much as we possibly can on the data that’s coming off of it. And so in a lot of places, we had multiple instrumentations or sensors associated with it given sort of component or process step or whatever it is that you’re looking for measurement system. And what was sort of interesting was to see — and this is sort of part of the purpose of a plant like that, frankly, is to see which of those are the right ones to use in our particular system and triangulating on the measurement systems that work the best.
And so yes, we’ve definitely learned some things there. I think we didn’t see anything shocking. Frankly, in a lot of cases, we would look at it and say, well, this seems like an unlikely right measurement system for this, but let’s put it in there anyway, because we might be surprised. And sometimes we were surprised and things worked when we didn’t expect them to from a sense of perspective and sometimes we weren’t surprised, and they didn’t work really all that well. Yes. So we’ve certainly been going through and learning a lot about that. Additionally, when you bring online a plant like this and you’re not quite sure which of the measurement systems are going to work out the best. You have to do a little bit of navigating through the data that you’re getting and that’s sort of a fun ride, frankly.
And if you spend time with our engineers on, they’ll tell you about that. But yes, generally speaking, I think things have worked out pretty much the way that we anticipated all the way through, it’s been surprising. As I said in my earlier comments, it was a challenging project first because all first kind plants are relatively challenging, but also because doing it through coated supply chain challenges, et cetera, made it even more so. But once you consider all of that, I think the plants performed really quite well. It’s been more well behaved than we expected it to be, frankly.
John Roberts : And then how long has Origin 1 run continuously near rated capacity? Has it run continuously in your rated capacity for weeks? At a time before you have to actually take it down and make an adjustment and so forth? And welcome, Matt as well.
John Bissell : We’re not really running at close to rated capacity yet. We weren’t planning to at this point. I think when we originally put together the ramp schedule for this plant, it was — we gave ourselves lots and lots of room to bring it all the way up to capacity. Specifically, this — as I mentioned in my prior comments, and I know you and I have talked about before, it’s really — you could think of this as a semi works tampon the front end and then it’s a continuous plant on the back end. And so part of what drives this is we’re running batches on the front end and then accumulating enough material that we can run the continuous back end. And so there’s some judgment involved in what’s the optimum way to learn on these different systems.
And we’re definitely still in that phase. We’re producing product, and we’re really happy with the way that we’re doing that. But we’re definitely not at the point that we can really give productivity data around much of the plant at this point. We could speculate and engineers — some engineers like to do that. But we’re not really prepared to make a comment at that like higher level yet, just not an updated yet.
John Roberts : Okay. Thank you.
Operator: Your next question will come from Eric Stine with Craig-Hallum.
Bassel Fouad: Hey, this is Bassel Fouad on for Eric Stein here. Can you guys just provide more details about the progress being made for financing for Origin 2? And is the $1.6 billion still anticipated for the CapEx?
John Bissell : Yes. So with respect to capital estimates, we really don’t have materially more information than we provided last quarter at this point. As we mentioned, we’re going through the revised fee package development. It takes some time to do the feedback development, and then it takes time after that to do the reestimation. So we really won’t have more information in the really near term, of course, we’ll report back on that when we get a chance to. The other point around sort of financing more broadly for Origin 2. I’d really refer back to Rich’s point on partnerships and partner interest there. We’ve seen a lot. I think a big part of this is going to be understanding what’s the right way to approach Origin 2, financing Origin 2 with the psyche partners and then also folding in some of the considerations around the around sort of licensing, technology licensing and partnership and scale up that could be other than this Origin 2 as well.
Yes. So I think that’s it. By the way, it sounds like an open line, so people could check their new.
Bassel Fouad: Got it. And then so noticing that the $10 billion demand has surpassed, are you guys expecting that kind of number for FDCA? And if so, do you guys have a time line for that?
Rich Riley : So I would say the $10 billion includes a wide variety of our products, including FDCA. We do not think we will have any problem with FDCA demand and like I referenced earlier, we continue to find more and more interesting applications for FDCA, where we get not just the sustainability benefit from the material, but also improved functional performance in really a wide variety of applications. And so similar to our PX and PET story for Origin demand is just not a problem.
Bassel Fouad: Awesome. All right. Thank you guys.
Operator:
Rich Riley : Thank you.
Operator: [Operator Instructions] Our next question will come from Pavel Molchanov with Raymond James Financial.
